Literature DB >> 6977610

Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers.

R Korngold, J Sprent.   

Abstract

Evidence is presented that T cells that produce lethal graft-vs.-host disease (GVHD) to minor histocompatibility antigens (minor HA) comprise discrete subgroups of H-2K- and H-2D-restricted T cells; double negative selection of T cells in irradiated H-2 recombinant mice was used to separate these two subgroups. No evidence could be found that I-restricted T cells contributed to GVHD, either as effector cells or helper cells. The (unprimed) precursor cells for GVHD expressed the Thy-1+, Lyt-1+/-2, Ia- phenotype. Studies in which H-2-semiallogeneic bone marrow chimeras were used as hosts for negative selection suggested that presentation of minor HA to T cells during the induction phase is controlled by marrow-derived cells; indirect evidence was obtained that these latter cells can "process" minor HA presented on H-2 different cells and thereby render the antigens immunogenic. Studies in which minor HA-different, H-2-compatible chimeras were re-irradiated and then injected with donor-vs.-host T cells suggested that the effector phase of lethal GVHD involves contact of antigen on non-marrow-derived cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6977610      PMCID: PMC2186609          DOI: 10.1084/jem.155.3.872

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

Review 1.  The role of microflora in development of graft-versus-host disease.

Authors:  M Pollard; C F Chang; K K Srivastava
Journal:  Transplant Proc       Date:  1976-12       Impact factor: 1.066

2.  Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted.

Authors:  P Matzinger; M J Bevan
Journal:  Cell Immunol       Date:  1977-09       Impact factor: 4.868

3.  Lymphocytes as models for the study of mammalian cellular differentiation.

Authors:  H Cantor; E A Boyse
Journal:  Immunol Rev       Date:  1977-01       Impact factor: 12.988

4.  Allograft immunity in the mouse. II. Physical studies of the development of cytotoxic effector cells from their immediate progenitors.

Authors:  H R MacDonald; R A Phillips; R G Miller
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

5.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

Review 6.  Cellular immunology and the pathogenesis of graft versus host reactions.

Authors:  W L Elkins
Journal:  Prog Allergy       Date:  1971

7.  T cell function in bone marrow chimeras: absence of host-reactive T cells and cooperation of helper T cells across allogeneic barriers.

Authors:  H von Boehmer; J Sprent
Journal:  Transplant Rev       Date:  1976

8.  The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens.

Authors:  M J Bevan
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

9.  Cell-mediated immune response in vitro. 3. The requirement for macrophages in cytotoxic reactions against cell-bound and subcellular alloantigens.

Authors:  H Wagner; M Feldmann; W Boyle; J W Schrader
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

10.  Function of macrophages in antigen recognition by guinea pig T lymphocytes. II. Role of the macrophage in the regulation of genetic control of the immune response.

Authors:  E M Shevach; A S Rosenthal
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  22 in total

1.  Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.

Authors:  Shoji Asakura; Daigo Hashimoto; Shuichiro Takashima; Haruko Sugiyama; Yoshinobu Maeda; Koichi Akashi; Mitsune Tanimoto; Takanori Teshima
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

Review 2.  GVHD: a continuing barrier to the safety of allogeneic transplantation.

Authors:  Pavan Reddy; Mukta Arora; Martin Guimond; Crystal L Mackall
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

3.  Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation.

Authors:  Isao Tawara; Motoko Koyama; Chen Liu; Tomomi Toubai; Dafydd Thomas; Rebecca Evers; Peter Chockley; Evelyn Nieves; Yaping Sun; Kathleen P Lowler; Chelsea Malter; Norihiro Nishimoto; Geoffrey R Hill; Pavan Reddy
Journal:  Clin Cancer Res       Date:  2010-11-03       Impact factor: 12.531

4.  Restricted recognition of H-2 subregion coded alloantigens in delayed-type hypersensitivity.

Authors:  A T Bianchi; H Bril; L M Hussaarts-Odijk; R Benner
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

5.  H-2-restricted graft-versus-host reaction: foreign determinants and restriction elements.

Authors:  B Kindred
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  H-2-restricted GVH reaction caused by T cells from normal donors of certain strains.

Authors:  B Kindred
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

7.  Roles of Host Nonhematopoietic Cells in Autoimmunity and Donor Cell Engraftment in Graft-versus-host Disease.

Authors:  Juyang Kim; Sohye Park; Hyun-A Kim; Daehee Jung; Hyun Ju Kim; Hye-Jeong Choi; Hong Rae Cho; Byungsuk Kwon
Journal:  Immune Netw       Date:  2010-04-30       Impact factor: 6.303

Review 8.  Graft-versus-host disease.

Authors:  James L M Ferrara; John E Levine; Pavan Reddy; Ernst Holler
Journal:  Lancet       Date:  2009-03-11       Impact factor: 79.321

9.  Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model.

Authors:  Stephen C Jones; George F Murphy; Thea M Friedman; Robert Korngold
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

10.  MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.

Authors:  Wei Sang; Cong Zhang; Dianzheng Zhang; Ying Wang; Cai Sun; Mingshan Niu; Xiaoshen Sun; Cui Zhou; Lingyu Zeng; Bin Pan; Wei Chen; Dongmei Yan; Feng Zhu; Qingyun Wu; Jiang Cao; Kai Zhao; Chong Chen; Zhenyu Li; Depeng Li; Thomas P Loughran; Kailin Xu
Journal:  Am J Hematol       Date:  2015-10-08       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.